Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
32 hedge funds and large institutions have $544M invested in Myovant Sciences Ltd. in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 4 closing their positions.
57% more capital invested
Capital invested by funds: $348M → $544M (+$197M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
7% more funds holding
Funds holding: 30 → 32 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$17.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$13.3M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.41M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$3.69M |
| 5 |
Millennium Management
New York
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.14M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$3.42M |
| 3 |
Janus Henderson Group
London,
|
-$1.18M |
| 4 |
JP Morgan Chase
New York
|
-$786K |
| 5 |
Lazard Asset Management
New York
|
-$417K |
MYOV Hedge Fund Activity: Q1 2019 in Review
32 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2019, worth a combined $544M — up 57% from $348M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MYOV positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $17.2M. The largest seller was Adage Capital Partners, cutting an estimated $6.14M.
- 32 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2019, up from 30 in Q4 2018.
- Funds reported $544M of Myovant Sciences Ltd. stock for Q1 2019, up 57% quarter-over-quarter.
- 6 funds opened new Myovant Sciences Ltd. positions in Q1 2019 and 4 closed out, a net change of +2 holders.
- The largest Myovant Sciences Ltd. buyer in Q1 2019 was Victory Capital Management, an estimated $17.2M added.
- The largest Myovant Sciences Ltd. seller in Q1 2019 was Adage Capital Partners, an estimated $6.14M sold.
Based on aggregated 13F filings for Q1 2019.